Genetic mutation linked with rare adrenal cancer:
This article was originally published in Clinica
New research has produced evidence to support the need for systematic gene testing in patients with pheochromocytoma, a rare form of adrenal cancer. US researchers have found that 24% of 271 pheochromocytoma patients tested carried one or more inherited mutations associated with the disease. The mutations, located in the VHL, RET, SDHB and SDHD genes, are significant as the patients would not have been considered at risk of developing the cancer, due to an absence of family history of other tumours or other personal medical history, report the investigators in The New England Journal of Medicine (May 9).
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.